26
Participants
Start Date
January 31, 2014
Primary Completion Date
April 30, 2015
Study Completion Date
January 31, 2017
Carfilzomib
Carfilzomib was administered by IV injection.
Karmanos Cancer Institute, Detroit
North Shore-LIJ Health System/Center for Advanced Medicine - North Shore University Hospital, Lake Success
Gabrail Cancer Center, Canton
Vanderbilt-Ingram Cancer Center, Henry-Joyce Cancer Clinic, Nashville
Baylor Charles A. Sammons Cancer Center, Dallas
UT Southwestern Medical Center, Dallas
Royal Prince Alfred Hospital, Camperdown
Royal Brisbane and Women's Hospital, Herston
Monash Health, Monash Medical Centre, Clayton
St. Vincent's Hospital Melbourne, Fitzroy
The Alfred Hospital, Malignant Haematology and Stem Cell Transplant Department, Melbourne
QEII Health Sciences Centre, Halifax
Sir Mortimer B. Davis-Jewish General Hospital, Montreal
Lead Sponsor
Amgen
INDUSTRY